EDITAS MEDICINE, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EDITAS MEDICINE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $228.00K, a 29.19% decline year-over-year.
- EDITAS MEDICINE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $322.00K, a 25.98% decline year-over-year.
- EDITAS MEDICINE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $435.00K, a 18.53% increase year-over-year.
- EDITAS MEDICINE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-06-30 was $367.00K.
- EDITAS MEDICINE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $424.00K, a 28.14% decline from fiscal 2024.
- EDITAS MEDICINE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $590.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2025-12-31 | $424.00K 10-K · filed 2026-03-09 | |
| 2025-06-30 | $228.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $590.00K 10-K · filed 2026-03-09 | |
| 2024-06-30 | $322.00K 10-Q · filed 2025-11-10 | |
| 2023-06-30 | $435.00K 10-Q · filed 2024-11-04 | |
| 2022-06-30 | $367.00K 10-Q · filed 2023-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |